Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

Medical professionals from across Texas gathered at DHR Health for the organization’s third annual wound care symposium. This was an event dedicated entirely to wound care for the first time, according to Dr. Noel Oliveira, Director of the Wound Care Center at DHR Hea